Astrana Health Stock Price, News & Analysis

Astrana Health (NASDAQ: ASTH) will release financial results for the third quarter ended September 30, 2025 after market close on Thursday, November 6, 2025. The company will host a conference call the same day at 2:30 p.m. PT / 5:30 p.m. ET to discuss results.

An accompanying PDF slide presentation will be posted on the company's IR Calendar page after the earnings release. Live dial-in numbers are 877-858-9810 and +1 201-689-8517; callers are asked to dial in about five minutes early. The call will be webcast and a recording will be available at the provided webcast link shortly after the call.

Astrana Health (NASDAQ: ASTH), a provider-centric, technology-powered healthcare company, has announced its participation in three major upcoming investor conferences in September 2025:

• Wells Fargo Healthcare Conference (September 3-4)
• Morgan Stanley Global Healthcare Conference (September 9) - Including a Fireside Chat from 5:35 PM to 6:10 PM ET
• Baird Healthcare Conference (September 10)

Astrana Health (NASDAQ: ASTH) reported strong Q2 2025 financial results, with total revenue reaching $654.8 million, up 35% year-over-year, and adjusted EBITDA of $48.1 million. The company's Care Partners segment led growth with revenue of $631.4 million, a 36% increase.

Key highlights include the completion of the Prospect Health acquisition for $707.9 million on July 1, 2025, financed through a five-year delayed draw term loan. The company also strengthened its leadership team with several strategic appointments, including Sherry McBride as COO.

Astrana reiterated its full-year 2025 guidance, projecting total revenue between $3.1-3.3 billion and adjusted EBITDA of $215-225 million, which includes the Prospect Health acquisition impact.

Astrana Health (NASDAQ: ASTH), a provider-centric healthcare technology company, has scheduled its Q2 2025 financial results announcement for Thursday, August 7, 2025, after market close.

The company will host a conference call at 2:30 PM PT/5:30 PM ET on the same day to discuss the results. Participants can join via phone (877-858-9810 or +1 201-689-8517) or webcast. A slide presentation will be available on the company's IR website, and a recording will be accessible after the call.

Astrana Health (NASDAQ: ASTH) has completed the acquisition of Prospect Health for $708 million, down from the initially announced $745 million. Prospect Health is a value-based care network with 11,000+ providers serving approximately 600,000 members across multiple states.

The acquisition is expected to contribute $1.2 billion in revenue and $81 million in adjusted EBITDA annually, with anticipated synergies of $12-15 million over the next 12-18 months. Astrana has updated its 2025 guidance to $3.1-3.3 billion in total revenue and $215-225 million in adjusted EBITDA.

Post-acquisition, Astrana will have $700 million in net debt and aims to reduce its net leverage ratio to below 2.5x within 12-18 months.

Astrana Health (NASDAQ: ASTH) has announced key additions to its senior leadership team to strengthen its AI-enabled healthcare delivery platform. Sherry McBride joins as Chief Operating Officer of Astrana Health - Management Services Organization, bringing 18 years of value-based healthcare operations experience from roles at Providence Health Network, Prospect Medical Systems, and CareMore Health. The company also appointed Georgie Sam as Chief Data and Analytics Officer, Glenn Sobotka as Chief Accounting Officer, and promoted Rita Pew to Chief People Officer. These strategic appointments aim to enhance Astrana's operational capabilities as it expands its national footprint to serve over 1.7 million patients. The leadership expansion focuses on strengthening core functions including operations, data, finance, and talent management to drive better outcomes for patients, physicians, and providers.

Astrana Health (NASDAQ: ASTH), a provider-centric healthcare technology company, announced its participation in the William Blair 2025 Growth Stock Conference in Chicago. Brandon Sim, President and CEO, will deliver a presentation on Wednesday, June 4, 2025, at 10:40 am CT. The conference runs from June 3-5, 2025. Investors can access the webcast through the IR Calendar section of Astrana's website at ir.astranahealth.com. Astrana Health focuses on enabling healthcare providers to deliver accessible, high-quality, and high-value care to patients.

Astrana Health (NASDAQ: ASTH) reported strong Q1 2025 financial results, with total revenue reaching $620.4 million, up 53% year-over-year. Care Partners revenue increased 57% to $601.0 million. However, net income decreased to $6.7 million from $14.8 million, with diluted EPS of $0.14 compared to $0.31 in Q1 2024.

The company announced key leadership additions, including Georgie Sam as Chief Data & Analytics Officer and Glenn Sobotka as Chief Accounting Officer. Astrana successfully integrated Collaborative Health Systems and received HSR approval for its pending Prospect Health acquisition. For Q2 2025, the company expects revenue between $615-655 million and adjusted EBITDA of $45-50 million. Full-year 2025 guidance projects revenue of $2.5-2.7 billion and adjusted EBITDA of $170-190 million.

Astrana Health (NASDAQ: ASTH), a provider-centric, technology-powered healthcare company, has announced its participation in the upcoming BofA Securities 2025 Health Care Conference in Las Vegas. The company's leadership, including President and CEO Brandon Sim and CFO/COO Chan Basho, will engage in a fireside chat scheduled for May 13, 2025, at 3:00 PM PT.

Investors and interested parties can access the webcast through the IR Calendar section on Astrana Health's investor relations website at ir.astranahealth.com/news-events/ir-calendar.